Association between Pk/Pd-Involved Gene Polymorphisms and Carbamazepine-Individualized Therapy

References

• Patsalos PN , BerryDJ , BourgeoisBFet al. Antiepileptic drugs – best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies . Epilepsia49 ( 7 ), 1239 – 1276 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Loscher W , KlotzU , ZimprichF , SchmidtD . The clinical impact of pharmacogenetics on the treatment of epilepsy . Epilepsia50 ( 1 ), 1 – 23 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Catterall WA , GoldinAL , WaxmanSG . International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels . Pharmacol. Rev.57 ( 4 ), 397 – 409 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Tate SK , DepondtC , SisodiyaSM , CavallertGL , SchorgeS . Genetic predictors of the maximum doses patients receive during clinical use of the anti-epileptic drugs carbamazepine and phenytoin . PNAS102 ( 15 ), 5507 – 5512 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Tate SK , SinghR , HungCCet al. A common polymorphism in the SCN1A gene associations with phenytoin serum levels at maintenance dose . Pharmacogenet. Genomics16 ( 10 ), 721 – 726 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Hung CC , ChangWL , HoJLet al. Association of polymorphisms in EPHX1, UGT2B7, ABCB1, ABCC2, SCN1A and SCN2A genes with carbamazepine therapy optimization . Pharmacogenomics13 ( 2 ), 159 – 169 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Abe T , SeoT , IshitsuT , NakagawaT , HoriM , NakagawaK . Association between SCN1A polymorphism and carbamazepine-resistant epilepsy . Br. J. Clin. Pharmacol.66 ( 2 ), 304 – 307 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Manna I , GambardellaA , BianchiAet al. A functional polymorphism in the SCN1A gene does not influence antiepileptic drug responsiveness in Italian patients with focal epilepsy . Epilepsia52 ( 5 ), e40 – e44 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Zimprich F , StogmannE , BonelliSet al. A functional polymorphism in the SCN1A gene is not associated with carbamazepine dosages in Austrian patients with epilepsy . Epilepsia49 ( 6 ), 1108 – 1109 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Kumari R , LakhanR , KumarSet al. SCN1AIVS5–91G>A polymorphism is associated with susceptibility to epilepsy but not with drug responsiveness . Biochimie95 ( 6 ), 1350 – 1353 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Kerr BM , ThummelKE , WurdenCJet al. Human liver carbamazepine metabolism. Role of CYP3A4 and CYP2C8 in 10,11-epoxide formation . Biochem. Pharmacol.47 ( 11 ), 1969 – 1979 ( 1994 ).
   PubMed Web of Science ®Google Scholar
• Korinthenberg R , HaugC , HannakD . The metabolization of carbamazepine to CBZ-10,11-epoxide in children from the newborn age to adolescence . Neuropediatrics25 ( 4 ), 214 – 216 ( 1994 ).
   PubMed Web of Science ®Google Scholar
• Battino D , EstienneM , AvanziniG . Clinical pharmacokinetics of antiepileptic drugs in paediatric patients. Part II. Phenytoin, carbamazepine, sulthiame, lamotrigine, vigabatrin, oxcarbazepine and felbamate . Clin. Pharmacokinet.29 ( 5 ), 341 – 369 ( 1995 ).
   PubMed Web of Science ®Google Scholar
• Kanarkowski R , RybakowskiJ . [Clinical pharmacokinetics of carbamazepine] . Psychiatr. Pol.23 ( 5–6 ), 379 – 386 ( 1989 ).
   PubMedGoogle Scholar
• Huang W , LinYS , McConnDNet al. Evidence of significant contribution from CYP3A5 to hepatic drug metabolism . Drug Metab. Dispos.32 ( 12 ), 1434 – 1445 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Dong ZL , LiH , ChenQXet al. Effect of CYP3A4*1G on the fentanyl consumption for intravenous patient-controlled analgesia after total abdominal hysterectomy in Chinese Han population . J. Clin. Pharm. Ther.37 ( 2 ), 153 – 156 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Park PW , SeoYH , AhnJY , KimKA , ParkJY . Effect of CYP3A5*3 genotype on serum carbamazepine concentrations at steady-state in Korean epileptic patients . J. Clin. Pharm. Ther.34 ( 5 ), 569 – 574 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Nakajima Y , SaitoY , ShisekiKet al. Haplotype structures of EPHX1 and their effects on the metabolism of carbamazepine-10,11-epoxide in Japanese epileptic patients . Eur. J. Clin. Pharmacol.61 ( 1 ), 25 – 34 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Maekawa K , ItodaM , HaniokaNet al. Non-synonymous single nucleotide alterations in the microsomal epoxide hydrolase gene and their functional effects . Xenobiotica33 ( 3 ), 277 – 287 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Hassett C , AicherL , SidhuJS , OmiecinskiCJ . Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants . Hum. Mol. Genet.3 ( 3 ), 421 – 428 ( 1994 ).
   PubMed Web of Science ®Google Scholar
• Staines AG , CoughtrieMW , BurchellB . N-glucuronidation of carbamazepine in human tissues is mediated by UGT2B7 . J. Pharmacol. Exp. Ther.311 ( 3 ), 1131 – 1137 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Lin GF , GuoWC , ChenJGet al. An association of UDP-glucuronosyltransferase 2B7 C802T (His268Tyr) polymorphism with bladder cancer in benzidine-exposed workers in China . Toxicol. Sci.85 ( 1 ), 502 – 506 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Bhasker CR , McKinnonW , StoneAet al. Genetic polymorphism of UDP-glucuronosyltransferase 2B7 (UGT2B7) at amino acid 268: ethnic diversity of alleles and potential clinical significance . Pharmacogenetics10 ( 8 ), 679 – 685 ( 2000 ).
   PubMedGoogle Scholar
• Ma H , ZhangT , GongZet al. Effect of UGT2B7 genetic variants on serum valproic acid concentration . Zhong Nan Da Xue Xue Bao Yi Xue Ban38 ( 8 ), 766 – 772 ( 2013 ).
   PubMedGoogle Scholar
• Potschka H , FedrowitzM , LoscherW . P-glycoprotein and multidrug resistance-associated protein are involved in the regulation of extracellular levels of the major antiepileptic drug carbamazepine in the brain . Neuroreport12 ( 16 ), 3557 – 3560 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Kim WJ , LeeJH , YiJet al. A nonsynonymous variation in MRP2/ABCC2 is associated with neurological adverse drug reactions of carbamazepine in patients with epilepsy . Pharmacogenet. Genomics20 ( 4 ), 249 – 256 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Grover S , Gourie-DeviM , BalaK , SharmaS , KukretiR . Genetic association analysis of transporters identifies ABCC2 loci for seizure control in women with epilepsy on first-line antiepileptic drugs . Pharmacogenet. Genomics22 ( 6 ), 447 – 465 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Qu J , ZhouBT , YinJYet al. ABCC2 polymorphisms and haplotype are associated with drug resistance in Chinese epileptic patients . CNS Neurosci. Ther.18 ( 8 ), 647 – 651 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Kim DW , LeeSK , ChuKet al. Lack of association between ABCB1, ABCG2, and ABCC2 genetic polymorphisms and multidrug resistance in partial epilepsy . Epilepsy Res.84 ( 1 ), 86 – 90 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Engel JJ . A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology . Epilepsia42 ( 6 ), 796 – 803 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Kwan P , ArzimanoglouA , BergATet al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies . Epilepsia51 ( 6 ), 1069 – 1077 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Ma C , JiaoZ , JieY , ShiX . Isocratic reversed-phase HPLC for simultaneous separation and determination of seven antiepileptic drugs and two of their active metabolites in human plasma . Chromatographia65 ( 5–6 ), 267 – 275 ( 2007 ).
   Web of Science ®Google Scholar
• Ma CL , WuXY , ZhengJ , WuZY , HongZ , ZhongMK . Association of SCN1A, SCN2A and ABCC2 gene polymorphisms with the response to antiepileptic drugs in Chinese Han patients with epilepsy . Pharmacogenomics15 ( 10 ), 1323 – 1336 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Power and sample size software provided by USC Biostats . http://biostats.usc.edu/software .
   Google Scholar
• YongYong Shi . Analysis tool for random samples . http://analysis.bio-x.cn/myAnalysis.php .
   Google Scholar
• Shi YY , HeL . SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci . Cell Res.15 ( 2 ), 97 – 98 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Li Z , ZhangZ , HeZet al. A partition-ligation-combination-subdivision EM algorithm for haplotype inference with multiallelic markers: update of the SHEsis ( http://analysis.bio-x.cn ). Cell Res.19 ( 4 ), 519 – 523 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Ma L , BallantyneC , BrautbarA , KeinanA . Analysis of multiple association studies provides evidence of an expression QTL hub in gene-gene interaction network affecting HDL cholesterol levels . PLoS ONE9 ( 3 ), e92469 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• R: the R Project for Statistical Computing . http://www.r-project.org/ .
   Google Scholar
• Zhou BT , ZhouQH , YinJYet al. Effects of SCN1A and GABA receptor genetic polymorphisms on carbamazepine tolerability and efficacy in Chinese patients with partial seizures: 2-year longitudinal clinical follow-up . CNS Neurosci. Ther.18 ( 7 ), 566 – 572 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Makmor-Bakry M , SillsGJ , HitirisN , ButlerE , WilsonEA , BrodieMJ . Genetic variants in microsomal epoxide hydrolase influence carbamazepine dosing . Clin. Neuropharmacol.32 ( 4 ), 205 – 212 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Puranik YG , BirnbaumAK , MarinoSEet al. Association of carbamazepine major metabolism and transport pathway gene polymorphisms and pharmacokinetics in patients with epilepsy . Pharmacogenomics14 ( 1 ), 35 – 45 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Zhu X , YunW , SunX , QiuF , ZhaoL , GuoY . Effects of major transporter and metabolizing enzyme gene polymorphisms on carbamazepine metabolism in Chinese patients with epilepsy . Pharmacogenomics15 ( 15 ), 1867 – 1879 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Kuehl P , ZhangJ , LinYet al. Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression . Nat. Genet.27 ( 4 ), 383 – 391 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Seo T , NakadaN , UedaNet al. Effect of CYP3A5*3 on carbamazepine pharmacokinetics in Japanese patients with epilepsy . Clin. Pharmacol. Ther.79 ( 5 ), 509 – 510 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Panomvana D , TraiyawongT , TowanabutS . Effect of CYP3A5 genotypes on the pharmacokinetics of carbamazepine when used as monotherapy or co-administered with phenytoin, phenobarbital or valproic acid in Thai patients . J. Pharm. Pharm. Sci.16 ( 4 ), 502 – 510 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Jang SY , KimMK , LeeKRet al. Gene-to-gene interaction between sodium channel-related genes in determining the risk of antiepileptic drug resistance . J. Korean Med. Sci.24 ( 1 ), 62 – 68 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Guo Y , HuC , HeX , QiuF , ZhaoL . Effects of UGT1A6, UGT2B7, and CYP2C9 genotypes on plasma concentrations of valproic acid in Chinese children with epilepsy . Drug Metab. Pharmacokinet.27 ( 5 ), 536 – 542 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Levesque E , DelageR , Benoit-BiancamanoMOet al. The impact of UGT1A8, UGT1A9, and UGT2B7 genetic polymorphisms on the pharmacokinetic profile of mycophenolic acid after a single oral dose in healthy volunteers . Clin. Pharmacol. Ther.81 ( 3 ), 392 – 400 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Peterkin VC , BaumanJN , GoosenTCet al. Limited influence of UGT1A1*28 and no effect of UGT2B7*2 polymorphisms on UGT1A1 or UGT2B7 activities and protein expression in human liver microsomes . Br. J. Clin. Pharmacol.64 ( 4 ), 458 – 468 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Chen P , YanQ , XuH , LuA , ZhaoP . The effects of ABCC2 G1249A polymorphism on the risk of resistance to antiepileptic drugs: a meta-analysis of the literature . Genet. Test. Mol. Biomarkers18 ( 2 ), 106 – 111 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Ufer M , von StulpnagelC , MuhleHet al. Impact of ABCC2 genotype on antiepileptic drug response in Caucasian patients with childhood epilepsy . Pharmacogenet. Genomics21 ( 10 ), 624 – 630 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Seo T , IshitsuT , OnikiK , AbeT , ShutoT , NakagawaK . ABCC2 haplotype is not associated with drug-resistant epilepsy . J. Pharm. Pharmacol.60 ( 5 ), 631 – 635 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Kwan P , WongV , NgPWet al. Gene-wide tagging study of the association between ABCC2, ABCC5 and ABCG2 genetic polymorphisms and multidrug resistance in epilepsy . Pharmacogenomics12 ( 3 ), 319 – 325 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Hilger E , ReinthalerEM , StogmannEet al. Lack of association between ABCC2 gene variants and treatment response in epilepsy . Pharmacogenomics13 ( 2 ), 185 – 190 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Lertratanangkoon K , HorningMG . Metabolism of carbamazepine . Drug Metab. Dispos.10 ( 1 ), 1 – 10 ( 1982 ).
   PubMed Web of Science ®Google Scholar